Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
32 pending office actions • 21 art units • 32 examiners • 0 of 32 (0%) have an AI response strategy ready • 64 patents granted in the last 365 days
The Industry-academic Cooperation Foundation, Yonsei University has 32 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 32 distinct examiners, meaning every pending matter is assigned to a different individual. This distribution is notable for a portfolio of this size. The workload spans 20 distinct art units, showing technical breadth within the biotechnology sector.
Colleen J O Toole is the busiest examiner, yet she only handles 1 pending office action. This fragmentation across the various examiners and 20 distinct art units suggests that the university's research output is highly diverse. Practitioners must prepare for many unique examiner perspectives, as no single examiner manages more than 1 of the pending actions. The involvement of the different art units indicates that the university is pursuing patents across many different sub-sectors. This decentralized approach ensures that no single examiner's decision impacts more than one of the 32 pending office actions.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §101 + other | 4 (12%) |
| §103 only | 5 (16%) |
| §102 only | 1 (3%) |
| Double-patenting + other | 2 (6%) |
| Multi-statute (no §101) | 19 (59%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| O TOOLE, COLLEEN J | 1 | 58.0% | +10.9% |
| LEE, HWA S | 1 | 72.3% | +3.1% |
| WRIGHT, ERIC BRANDON | 1 | — | — |
| RAEVIS, ROBERT R | 1 | 83.3% | +15.3% |
| TICHY, JENNIFER M.H. | 1 | 64.9% | +34.5% |
| TIWARI, VYOMA SHUBHAM | 1 | 31.5% | +48.1% |
| BARRON, SEAN C | 1 | 52.9% | +30.9% |
| WELLS, LAUREN QUINLAN | 1 | 48.4% | +60.3% |
| SHOMER, ISAAC | 1 | 63.2% | +30.4% |
| GILL, RACHEL B | 1 | 65.6% | +28.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18254494 | NEEDLE AND SYRINGE USING SAME | PATEL, SHEFALI DILIP | 49d overdue |
| 18006447 | METHOD FOR PREPARING CULTURED MEAT ON BASIS OF CELL COATING TECHNIQUE, AND CULTURED MEAT PREPARED THEREBY | TRAN, LIEN THUY | 23d overdue |
| 17752235 | OPERATION DEVICE OF CONVOLUTIONAL NEURAL NETWORK, OPERATION METHOD OF CONVOLUTIONAL NEURAL NETWORK AND COMPUTER PROGRAM STORED IN A RECORDING MEDIUM TO EXECUTE THE METHOD THEREOF | LAROCQUE, EMILY E | 10d overdue |
| 17972933 | METHOD AND APPARATUS FOR GENERATING SYNTHETIC DATA | COLE, BRANDON S | 22d |
| 19279137 | FREQUENCY MULTIPLIER CIRCUITS HAVING CROSSCOUPLED CAPACITORS THEREIN WHICH SUPPORT FREQUENCY MULTIPLICATION | O TOOLE, COLLEEN J | — |
| 18989928 | METHOD AND COMPUTER PROGRAM FOR PREDICTING PARAMETER OF SAMPLE IN OPTICAL MEASUREMENT SYSTEM, AND RECORDING MEDIUM STORING COMPUTER PROGRAM FOR IMPLEMENTING SAME | LEE, HWA S | — |
| 18711180 | FEED COMPOSITION FOR CONSTRUCTION OF STEATOHEPATITIS ANIMAL MODEL | WRIGHT, ERIC BRANDON | — |
| 18817640 | THERMAL RUNAWAY DETECTION AND CONTROL DEVICE AND METHOD THEREOF | RAEVIS, ROBERT R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19279137 | FREQUENCY MULTIPLIER CIRCUITS HAVING CROSSCOUPLED CAPACITORS THEREIN WHICH SUPPORT FREQUENCY MULTIPLICATION | O TOOLE, COLLEEN J | — |
| 18817640 | THERMAL RUNAWAY DETECTION AND CONTROL DEVICE AND METHOD THEREOF | RAEVIS, ROBERT R | — |
| 18780488 | Artificial tissue for transplantation therapy, drug screening, Manufacturing method thereof, and Manufacturing apparatus therefor | TICHY, JENNIFER M.H. | — |
| 18713030 | TUMOR TISSUE MODEL FOR CULTURING TUMOR TISSUE | TIWARI, VYOMA SHUBHAM | — |
| 18708373 | COMPOSITION COMPRISING DECELLULARIZED UTERINE TISSUE-DERIVED EXTRACELLULAR MATRIX AND USE THEREOF | BARRON, SEAN C | — |
| 18706095 | USE OF APOMORPHINE AS THERAPEUTIC AGENT FOR NECROPTOSIS-RELATED DISEASES | WELLS, LAUREN QUINLAN | — |
| 18702663 | HYDROGEL INCLUDING PHENOL DERIVATIVE-MODIFIED CELLULOSE AND USE THEREOF | SHOMER, ISAAC | — |
| 18699219 | PEPTIDE TARGETING FUSOBACTERIA, COMPOSITION FOR DIAGNOSING CANCER COMPRISING SAME, AND DRUG DELIVERY COMPOSITION | GILL, RACHEL B | — |
| Art Unit | Apps |
|---|---|
| 1795 | 2 |
| 2877 | 1 |
| 1612 | 1 |
| 1625 | 1 |
| 2474 | 1 |
| 1624 | 1 |
| 1682 | 1 |
| 1626 | 1 |
| 1629 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19279137 | FREQUENCY MULTIPLIER CIRCUITS HAVING CROSSCOUPLED CAPACITORS THEREIN WHICH SUPPORT FREQUENCY MULTIPLICATION | O TOOLE, COLLEEN J | — | §101§102§103Other | Non-Final OA | — | Pending | Jul 24, 2025 |
| 18989928 | METHOD AND COMPUTER PROGRAM FOR PREDICTING PARAMETER OF SAMPLE IN OPTICAL MEASUREMENT SYSTEM, AND RECORDING MEDIUM STORING COMPUTER PROGRAM FOR IMPLEMENTING SAME | LEE, HWA S | 2877 | §101§112 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18711180 | FEED COMPOSITION FOR CONSTRUCTION OF STEATOHEPATITIS ANIMAL MODEL | WRIGHT, ERIC BRANDON | — | §102§103§112 | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18817640 | THERMAL RUNAWAY DETECTION AND CONTROL DEVICE AND METHOD THEREOF | RAEVIS, ROBERT R | — | §103§112 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18780488 | Artificial tissue for transplantation therapy, drug screening, Manufacturing method thereof, and Manufacturing apparatus therefor | TICHY, JENNIFER M.H. | — | §103§112 | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18713030 | TUMOR TISSUE MODEL FOR CULTURING TUMOR TISSUE | TIWARI, VYOMA SHUBHAM | — | §102§103§112 | Non-Final OA | — | Pending | May 23, 2024 |
| 18708373 | COMPOSITION COMPRISING DECELLULARIZED UTERINE TISSUE-DERIVED EXTRACELLULAR MATRIX AND USE THEREOF | BARRON, SEAN C | — | §102 | Non-Final OA | — | Pending | May 08, 2024 |
| 18706095 | USE OF APOMORPHINE AS THERAPEUTIC AGENT FOR NECROPTOSIS-RELATED DISEASES | WELLS, LAUREN QUINLAN | — | §102§103§112 | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18702663 | HYDROGEL INCLUDING PHENOL DERIVATIVE-MODIFIED CELLULOSE AND USE THEREOF | SHOMER, ISAAC | 1612 | §102§103 | Final Rejection | — | Pending | Apr 18, 2024 |
| 18699219 | PEPTIDE TARGETING FUSOBACTERIA, COMPOSITION FOR DIAGNOSING CANCER COMPRISING SAME, AND DRUG DELIVERY COMPOSITION | GILL, RACHEL B | — | §102§103§112 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18294422 | PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT | RZECZYCKI, PHILLIP MATTHEW | 1625 | §102§103§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18292109 | METHOD AND DEVICE FOR SUPPORTING MULTIPLE ACCESS BY USING SWITCH NETWORK | MENSAH, PRINCE AKWASI | 2474 | §103 | Final Rejection | 17d overdue | Pending | Jan 25, 2024 |
| 18580971 | COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES, COMPRISING STC-1 OR DERIVATIVE THEREOF | STEELE, AMBER D | — | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18399675 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | ROMERO, KRISTEN WANG | 1624 | §102§103§112 | Non-Final OA | — | Pending | Dec 28, 2023 |
| 18565775 | METHOD FOR PROVIDING RARE SUGAR ASSIMILATION ABILITY DETERMINING GENE CLUSTER OF RARE SUGAR NON-METABOLIC STRAIN | JONES, CHRISTINE MICHELLE | 1682 | §103§112 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18279348 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | HAVLIN, ROBERT H | 1626 | §102§112 | Non-Final OA | — | Pending | Aug 29, 2023 |
| 18546830 | COMPOSITION FOR TREATMENT OF ANTICANCER DRUG RESISTANCE | SEITZ, ANTHONY JOSEPH | 1629 | §102§103§112DP | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18254494 | NEEDLE AND SYRINGE USING SAME | PATEL, SHEFALI DILIP | 3783 | §103§112 | Final Rejection | 49d overdue | Pending | May 25, 2023 |
| 18305342 | Novel Animal Model for Autoimmune Disease | WILSON, MICHAEL C | 1638 | §103§112 | Non-Final OA | — | Pending | Apr 22, 2023 |
| 18006446 | METHOD FOR PRODUCING CULTURED MEAT ON BASIS OF CELL SHEET COATING TECHNIQUE, AND CULTURED MEAT PRODUCED THEREBY | WESTON, ALYSSA G | 1633 | §103§112DP | Non-Final OA | — | Pending | Mar 30, 2023 |
| 18022902 | CATHETER-TYPE ULTRASOUND ENDOSCOPE AND EXAMINATION SYSTEM INCLUDING SAME | VIRK, ADIL PARTAP S | 3798 | §103§112 | Final Rejection | — | Pending | Feb 23, 2023 |
| 18007241 | SYSTEM AND METHOD FOR PRIME EDITING EFFICIENCY PREDICTION USING DEEP LEARNING | ELKINS, BLAKE HARRISON | — | §101§103§112Other | Non-Final OA | — | Pending | Jan 27, 2023 |
| 18006447 | METHOD FOR PREPARING CULTURED MEAT ON BASIS OF CELL COATING TECHNIQUE, AND CULTURED MEAT PREPARED THEREBY | TRAN, LIEN THUY | 1793 | §103§112 | Final Rejection | 23d overdue | Pending | Jan 23, 2023 |
| 18056693 | ELECTROCHEMICAL BIOSENSOR FOR DETECTING TARGET RNA | SUN, CAITLYN MINGYUN | 1795 | §103§112 | Final Rejection | — | Pending | Nov 17, 2022 |
| 17972933 | METHOD AND APPARATUS FOR GENERATING SYNTHETIC DATA | COLE, BRANDON S | 2128 | §101 | Non-Final OA | 22d | Pending | Oct 25, 2022 |
| 18046402 | METHOD OF PREPARING PLATINUM-BASED ALLOY CATALYST | YUEN, JACKY | 1735 | §103 | Non-Final OA | — | Pending | Oct 13, 2022 |
| 17958595 | METAL/CARBON-DIOXIDE BATTERY AND HYDROGEN PRODUCTION AND CARBON DIOXIDE STORAGE SYSTEM COMPRISING SAME | HANSEN, JARED A | 1723 | §103 | Non-Final OA | — | Pending | Oct 03, 2022 |
| 17904381 | METHOD FOR PREPARING FIBROSIS-ENCAPSULATED TUMOROID, AND USE THEREOF | REGLAS, GILLIAN CHELSEA | 1632 | §102§103 | Final Rejection | — | Pending | Aug 17, 2022 |
| 17889135 | METHOD AND APPARATUS FOR ESTIMATING EXECUTION TIME OF NEURAL NETWORK | DRAPEAU, SIMEON PAUL | 2188 | §101§102§103 | Non-Final OA | — | Pending | Aug 16, 2022 |
| 17816547 | GAS SENSOR, SCANNING ELECTROCHEMICAL GAS MICROSCOPE, AND METHOD OF PREPARING GAS SENSOR | QIAN, SHIZHI | 1795 | §103 | Final Rejection | — | Pending | Aug 01, 2022 |
| 17752235 | OPERATION DEVICE OF CONVOLUTIONAL NEURAL NETWORK, OPERATION METHOD OF CONVOLUTIONAL NEURAL NETWORK AND COMPUTER PROGRAM STORED IN A RECORDING MEDIUM TO EXECUTE THE METHOD THEREOF | LAROCQUE, EMILY E | 2182 | §103§112 | Final Rejection | 10d overdue | Pending | May 24, 2022 |
| 17252771 | COMPOSITION COMPRISING FLT3 INHIBITOR AS EFFECTIVE INGREDIENT FOR INHIBITING DRUG RESISTANCE IN CHRONIC MYELOGENOUS LEUKEMIA | COPPINS, JANET L | 1628 | §103 | Final Rejection | — | Pending | Dec 16, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial